20-5314116-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM5
The NM_144773.4(PROKR2):c.254G>T(p.Arg85Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000329 in 1,614,150 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R85H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_144773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROKR2 | NM_144773.4 | c.254G>T | p.Arg85Leu | missense_variant | 2/3 | ENST00000678254.1 | NP_658986.1 | |
PROKR2 | XM_017027646.2 | c.254G>T | p.Arg85Leu | missense_variant | 2/4 | XP_016883135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.254G>T | p.Arg85Leu | missense_variant | 2/3 | NM_144773.4 | ENSP00000504128 | P1 | ||
PROKR2 | ENST00000217270.4 | c.254G>T | p.Arg85Leu | missense_variant | 2/3 | 1 | ENSP00000217270 | P1 | ||
PROKR2 | ENST00000678059.1 | c.146G>T | p.Arg49Leu | missense_variant | 2/3 | ENSP00000503366 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152154Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000326 AC: 82AN: 251490Hom.: 0 AF XY: 0.000294 AC XY: 40AN XY: 135922
GnomAD4 exome AF: 0.000321 AC: 469AN: 1461878Hom.: 0 Cov.: 34 AF XY: 0.000309 AC XY: 225AN XY: 727246
GnomAD4 genome AF: 0.000407 AC: 62AN: 152272Hom.: 1 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 85 of the PROKR2 protein (p.Arg85Leu). This variant is present in population databases (rs74315418, gnomAD 0.05%). This missense change has been observed in individual(s) with PROKR2-related conditions (PMID: 20022991, 23386640, 31093944). ClinVar contains an entry for this variant (Variation ID: 338863). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PROKR2 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PROKR2 function (PMID: 29161432, 36694982). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
PROKR2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 30, 2024 | The PROKR2 c.254G>T variant is predicted to result in the amino acid substitution p.Arg85Leu. This variant has been reported in the heterozygous state in a patient with Kallmann syndrome (Sarfati et al. 2010. PubMed ID: 20022991, table 2). This variant has also been reported in the heterozygous state in a patient with hypopituitarism and septo-optic dysplasia (McCabe et al. 2013. PubMed ID: 23386640, table 1). In vitro functional assays showed the p.Arg85Leu variant could markedly impair cell surface expression of the receptor when it was tested alone (Sbai et al. 2014. PubMed ID: 24830383; Cox et al. 2018. PubMed ID: 29161432). However, when co-transfected with wild-type and the p.Arg85Leu, the p.Arg85Leu variant could be rescued by the presence of WT PROKR2 in 2 out of 3 signaling pathways, suggesting this variant might be a milder variant that may rely upon the genetic context for its phenotypic penetrance (Cox et al. 2018. PubMed ID: 29161432, table S2). A few different variants affecting the same amino acid (p.Arg85Gly, p.Arg85Cys and p. Arg85His) have been reported in association with Kallman syndrome (Human Gene Mutation Database, HGMD; http://www.hgmd.cf.ac.uk/). This variant is reported in 0.049% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Seizure Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 10, 2019 | The inherited c.254G>T (p.Arg85Leu) variant in PROKR2 substitutes a highly conserved Arginine for Leucine at amino acid 85/385 (coding exon 2/3). It is found in gnomAD (7 heterozygous individuals, 0 homozygous individuals, allele frequency: 2.2e-4) and ExAC (38 heterozygous individuals, 0 homozygous individuals; allele frequency: 3.13e-4). In silico algorithms predict that this variant is Deleterious (Provean; score: -5.97) and Damaging (SIFT; score: 0.000) to the function of the canonical transcript. This variant is reported in ClinVar with a single submission lacking supporting evidence as Likely Benign (VarID:338863), however different amino acid changes at the same residuehave been reported as Pathogenic, Likely Pathogenic, or as a Variant of Uncertain Significance (p.Arg85His; p.Arg85Gly; Arg85Cys). The Arg85 residue is at the first intracellular loop, and functional studies have suggested that the p.Arg85Leu variant has a mild G-protein coupling defectas well as reduced quantity of protein present at the cell surface [PMID: 24830383].This variant has been identified inindividuals in the literature with Kallmann syndrome or pituitary hormone deficiency [PMID: 24031091; PMID: 23386640]. The inherited c.254G>T (p.Arg85Leu) variant is reported here as a Variant of Uncertain Significance. - |
Hypogonadotropic hypogonadism 3 with or without anosmia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at